Please Wait.....
Report
Japan Wound Care Market Assessment, By Product [Advanced Wound Dressings, Surgical Wound Care, Traditional Wound Care, Wound Therapy Devices], By Applications [Chronic Wounds, Acute Wounds], Mode of Purchase [Prescribed, Non-prescribed], Distribution Channel [Institutional Sales, Retail Sales], By End-user [Hospitals, Outpatient Facilities, Home care, Research & Manufacturing], By Region, Opportunities and Forecast, FY2017-FY2031F
Market Report I 2024-04-19 I 128 Pages I Market Xcel - Markets and Data
Japan Wound Care Market size was valued at USD 1.61 billion in FY2023, and is expected to reach USD 2.39 billion in FY2031, with a CAGR of 5.1% for the forecast period between FY2024 and FY2031. The Japan wound care market is anticipated to grow, driven by factors such as the growing elderly demographic in Japan, a rising incidence of chronic diseases such as diabetes, and technological advancements. Given the elderly's susceptibility to skin issues and their need for specialized wound care, the rise in demographics is a significant concern.
According to the Ministry of Internal Affairs and Communications' population estimates, the number of individuals aged 65 and older increased by 60,000 in 2022, reaching a historical high of 36.27 million. An article published in the Journal of Nursing highlights how skin damage in the elderly, resulting from increased friction and shear forces, contributes to pressure ulcer development. Therefore, the growing elderly population is expected to be a contributing factor to the growth of the market. Furthermore, the implementation of updated wound care management protocols fosters greater unity in healthcare teams and is expected to boost market expansion. In April 2022, the Japanese Society for Burn Injuries (JSBI) released the third iteration of guidelines for inpatient burn injury treatment in Japan. The initiative aims to establish a collective approach to burn care and promote new research to substantiate evidence-based burn care and treatment practices.
Increasing Prevalence of Diabetes
One of the most common outcomes of inadequately managed diabetes mellitus is the development of diabetic foot ulcers. These ulcers typically result from inadequate foot care, peripheral vascular disease, neuropathy, and poor glycemic control. As per data from the IDF Diabetes Atlas 2021, it indicates that an estimated 11.0 million individuals aged 20-79 in Japan had diabetes. Consequently, the substantial diabetes burden in the country elevates the risk of diabetic foot ulcers, necessitating effective wound care and likely contributing to market growth during the forecast period. Moreover, the substantial prevalence and occurrence of diabetic foot ulcers are projected to make the primary wound type, necessitating wound care management in the Japanese population. As per an article published in the Journal of Foot and Ankle Research, the incidence of diabetic foot ulcers in Japan was reported at 2.9 cases per 1000 people. This heightened risk of wound complications associated with diabetes is anticipated to stimulate the demand for wound care management devices in Japan.
Product Launch and Product Approvals
Japan wound care market has witnessed several notable product approvals and launches in recent months. Among these, innovative wound dressings with advanced materials and enhanced antimicrobial properties have gained regulatory approval. These cutting-edge solutions promise improved healing outcomes and infection prevention, addressing the growing need for effective wound management in Japan's aging population. Additionally, the introduction of smart wound care technologies, including connected devices and remote monitoring systems, has added a new dimension to patient care. These advancements signify a promising era of progress and improved patient outcomes in Japan wound care market.
In June 2021, MIMEDX Group, Inc. obtained regulatory clearance from the Japan MHLW (Ministry of Health, Labor and Welfare) for the introduction of EPIFIX in the Japanese market. EPIFIX received approval for the treatment of challenging-to-heal chronic wounds, notably diabetic foot ulcers. Its purpose is to safeguard the wound bed, promote granulation tissue formation, and provide a biocompatible human extracellular matrix. Consequently, the approval of novel products and their superior benefits are contributing to the increased adoption of wound care solutions.
Collaborations Among Leading Industry Players
Japan wound care market has witnessed several collaborations among leading industry players, fostering innovation and advancements in Japan wound care market. The partnerships aim to address the growing demand for wound care solutions, driven by an aging population and rising incidence of chronic wounds. The collaborations include pharmaceutical companies collaborating with medical device manufacturers to develop integrated wound management systems. Furthermore, wound care product manufacturers often collaborate with research institutions and healthcare providers to conduct clinical trials and studies that enhance product efficacy and safety. These partnerships are accelerating the introduction of cutting-edge wound care technologies, like advanced dressings and regenerative therapies.
In January 2023, MiMedx Group, Inc. entered an exclusive distribution partnership with Gunze Medical Limited to market EPIFIX in Japan, providing a well-established treatment choice for individuals managing chronic wounds.
Impact of COVID-19
The COVID-19 pandemic significantly influenced market growth, primarily due to disruptions in wound care management. For Instance, a study published in the Journal of General Internal Medicine in May 2021 revealed a 61% reduction in diabetic foot care services in Japan during the pandemic. Consequently, the COVID-19 outbreak substantially impacted market growth during this period. Nevertheless, telemedicine services in the region have played a vital role in enabling patients to maintain their healthcare management, including wound care. After the pandemic, areas affected by the pandemic had considerably increased access to telehealth through mobile apps, facilitating improved healthcare management.
Key Players Landscape and Outlook
Japan, being an advanced nation with established trade connections with other developed countries, attracts numerous international participants to its wound care management market. Additionally, several domestic Japanese companies also operate in this sector. Consequently, the Japanese wound care management market has become highly competitive and diversified, boasting a multitude of players. Notable companies in this market landscape include Smith & Nephew, Medtronic, B. Braun SE, 3M, and Coloplast Group.
In April 2023, Gunze Medical, commenced the direct distribution of products such as artificial dermis marketed as PELNAC, wound dressings, and various other medical devices tailored for wound care within the Japanese market.
1. Research Methodology
2. Project Scope & Definitions
3. Impact of COVID-19 on Japan Wound Care Market
4. Executive Summary
5. Japan Wound Care Market Outlook, FY2017-FY2031F
5.1. Market Size & Forecast
5.1.1. By Value
5.1.2. By Volume
5.2. By Product
5.2.1. Advanced Wound Dressings
5.2.1.1. Foam Dressings
5.2.1.2. Hydrocolloid Dressings
5.2.1.3. Film Dressings
5.2.1.4. Alginate Dressings
5.2.1.5. Hydrogel Dressings
5.2.1.6. Collagen Dressings
5.2.1.7. Others
5.2.2. Surgical Wound Care
5.2.2.1. Sutures & Staples
5.2.2.2. Tissue Adhesive and Sealants
5.2.2.3. Anti-Infective Dressing
5.2.3. Traditional Wound Care
5.2.3.1. Medical Tapes
5.2.3.2. Cotton
5.2.3.3. Bandages
5.2.3.4. Gauzes
5.2.3.5. Sponges
5.2.3.6. Cleansing Agents
5.2.4. Wound Therapy Devices
5.2.4.1. Negative Pressure Wound Therapy
5.2.4.2. Oxygen And Hyperbaric Oxygen Equipment
5.2.4.3. Electric Stimulation Devices
5.2.4.4. Pressure Relief Devices
5.2.4.5. Others
5.3. By Applications
5.3.1. Chronic Wounds
5.3.1.1. Diabetic Foot Ulcers
5.3.1.2. Pressure Ulcers
5.3.1.3. Venous Leg Ulcers
5.3.1.4. Other
5.3.2. Acute Wounds
5.3.2.1. Surgical & Traumatic Wounds
5.3.2.2. Burns
5.4. By End-user
5.4.1. Hospitals
5.4.2. Outpatient Facilities
5.4.3. Home Care
5.4.4. Research & Manufacturing
5.5. Mode of Purchase
5.5.1. Prescribed
5.5.2. Non-prescribed (OTC)
5.6. Distribution Channel
5.6.1. Institutional Sales
5.6.2. Retail Sales
5.7. By Region
5.7.1. North [Hokkaido and Tohoku]
5.7.2. Central [Kanto and Chubu]
5.7.3. South [Kansai, Chugoku, Shikoku, and Kyushu & Okinawa].
5.8. By Company Market Share (%), FY2023
6. Market Mapping, FY2023
6.1. By Product
6.2. By Application
6.3. By End-User
6.4. By Mode of Purchase
6.5. Distribution Channel
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis - Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
7.4.1. Political Factors
7.4.2. Economic System
7.4.3. Social Implications
7.4.4. Technological Advancements
7.4.5. Environmental Impacts
7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
7.5.1. Supplier Power
7.5.2. Buyer Power
7.5.3. Substitution Threat
7.5.4. Threat from New Entrant
7.5.5. Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Smith & Nephew
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. 3M Company
13.3. B. Braun Melsungen AG
13.4. Cardinal Health Inc.
13.5. Coloplast A/S
13.6. ConvaTec Group PLC
13.7. Integra Lifesciences
13.8. Medtronic PLC
13.9. Molnlycke Health Care
13.10. Paul Hartmann AG
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security